SOLENO THERAPEUT. DL-001 (6XC) — Working Capital to Net Assets Ratio
SOLENO THERAPEUT. DL-001 (6XC) has a Working Capital to Net Assets ratio of 65.4% as of December 2025. Working capital of €294.45 Million (current assets of €355.81 Million minus current liabilities of €61.36 Million) is measured against net assets of €450.12 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SOLENO THERAPEUT. DL-001 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SOLENO THERAPEUT. DL-001 Working Capital to Net Assets (2021–2025)
This chart shows how SOLENO THERAPEUT. DL-001's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 65.4%, reflecting working capital of €294.45 Million against net assets of €450.12 Million EUR. For the complete balance sheet picture, see 6XC asset base.
Annual Working Capital to Net Assets for SOLENO THERAPEUT. DL-001 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SOLENO THERAPEUT. DL-001 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check SOLENO THERAPEUT. DL-001 (6XC) asset resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 65.4% | €294.45 Million | €450.12 Million | €355.81 Million | €61.36 Million | ▼ -46.8 pp |
| 2024 | 112.3% | €275.14 Million | €245.11 Million | €293.89 Million | €18.75 Million | ▲ +10.8 pp |
| 2023 | 101.5% | €159.85 Million | €157.51 Million | €171.36 Million | €11.51 Million | ▲ +21.0 pp |
| 2022 | 80.5% | €8.33 Million | €10.35 Million | €15.65 Million | €7.31 Million | ▼ -0.5 pp |
| 2021 | 81.0% | €14.41 Million | €17.79 Million | €22.42 Million | €8.01 Million | — |